BioNTech AG ("BioNTech") and SiO2 Medical Products, Inc. ("SMP") announce a common testing of SMP's high performance primary packaging container to preserve BioNTech´s mRNA products for cancer-immunotherapy. Following the completion of successful process evaluations involving leading fill-/finish-machine manufacturers, SMP and BioNTech want to explore and develop superior packaging as well as application devices manufactured by SMP for a range of BioNTech mRNA products.
Vanrx Pharmasystems ("Vanrx") and SiO2 Medical Products, Inc. ("SMP") are announcing that SMP is joining the Matrix Alliance. In joining the Matrix Alliance, SMP will collaborate with other member companies on pharmaceutical manufacturing and packaging technologies in four key areas: (1) Testing of pre-sterilized container and nested closure systems for parenteral (injectable) medicines; (2) Ensuring the compatibility of components from different members; (3) Driving industry awareness of those solutions; and (4) Collaborating on industry education regarding new primary packaging solutions. SMP’s array of sterilized packaging products, including our 2, 6, and 10 mL vials incorporating a proprietary coating technology, readily integrate into Vanrx filling machines and are compatible with the closure systems from our Matrix Alliance partners.
SiO2 Medical Products will be featured in the PDA Journal of Pharmaceutical Science and Technology's November/December 2017 issue. The article, "Inhibiting sterilization-induced oxidation of large molecule therapeutics packaged in plastic parenteral vials," discusses the benefits of coated plastic parenteral vials in preventing oxidative damage to sensitive drugs. Click the link to read the electronic version of the article.
SiO2 Medical Products will be presenting at the Berkshire Sterile Manufacturing Innovation Day on October 19th in Lee, MA. The presentation, titled “Next Generation Primary Packaging for Parenterals,” will discuss the benefits of SMP's innovative containers to our customers and how material science is changing the parenteral industry.
SiO2 Medical Products, Inc. (“SMP”) announced the signing of an agreement for the manufacture and commercialization of multi-well plates treated with BioDep™ tissue coating technologies developed by TheraDep Technologies, Inc.
SiO2 Medical Products, Inc. and Sanaria Inc., a U.S.-based developer, manufacturer, and supplier of vaccines, today announced the signing of an agreement for the development, manufacture, and supply of cryogenic vials for Sanaria’s malaria vaccine, Sanaria® PfSPZ Vaccine.
SiO2 Medical Products has developed a series of technical reports to help elaborate on relevant test findings and the subsequent benefits to our customers.
SiO₂ Medical Products, Inc. received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines Authority BfArM on November 25, 2016. Click below to read the full press release.
SiO₂ Medical Products, Inc.'s Chief Scientist, Dr. Christopher Weikart, presented on "Next Generation Lubricant Technology for Parenteral Syringes and Cartridges." Click below to read the presentation.
SiO₂ Medical Products will be exhibiting at PDA: Universe of Pre-filled Syringes in Huntingdon Beach, California October 17-18. Our Chief Scientist, Dr. Christopher Weikart, will also be presenting on "Next Generation Lubricant Technology for Parenteral Syringes and Cartridges."
Read the interview with SiO₂ Medical Products, Inc.'s Brian Maurer & Amer El-Hage on “A New Application for an Existing Technology” which describes the benefits of SiO₂ Medical Products' Advanced Surface Treated Labware as highlighted in SLAS’s Electronic Library Network.
Read the presentation given at the PDA/FDA Joint Regulatory Conference on September 13th, discussing "Advanced In-Process Monitoring & Traceability for Primary Container Manufacturing."
© 2016 SiO₂ Medical Products, Inc.